Abstract:
본 발명은 항암효과를 갖는 신규의 지방산락톤(Fatty Acid Lactones) 유도체 및 그 추출방법에 관한 것으로, 본 발명에 의한 지방산락톤 유도체는, 아래의 구조식(Ⅰ) 및 (Ⅱ)와 같이 이루어져 있고, 강장동물, 특히 히드라(Hydroid) 솔란데리아 세쿤다(Solanderia Secunda)로부터 유기용매로 용출하여 크로마토그래피 방법에 의해 분리추출하며, 파내실 단백질 전이효소(Farnesyl Protein Transferase)의 작용을 저해하여 Ras 유전자의 파내실화를 방지하는 기능을 함으로써 항암작용을 하는 것으로 밝혀진 것이다.
Abstract:
본 발명은 항암효과를 갖는 신규의 지방산락톤(fatty acid lactones) 유도체 및 그 추출방법에 관한 것으로, 본 발명에 의한 지방산락톤 유도체는, 아래의 구조식(I) 및 (Ⅱ)와 같이 이루어져 있고, 강장동물, 특히 히드라(hydroid) 솔란데리아 세쿤다(Solanderia secunda)로부터 유기용매로 용출하여 크로마토그래피 방법에 의해 분리추출하며, 파내실 단백질 전이효소(farnesyl protein transferase)의 작용을 저해하여 Ras 유전자의 파내실화를 방지하는 기능을 함으로써 항암작용을 하는 것으로 밝혀진 것이다.
Abstract:
본 발명은 신규한 브로모페놀계 화합물, 그 제조방법 및 이를 유효성분으로 포함하는 항균 조성물에 관한 것이다. 상기 신규한 브로모페놀계 화합물은 기존에 알려진 화합물에 비하여 그람 양성균 및 그람 음성균에 속하는 위해세균 특히, 스테필로코코스속 균( Staphylococcus . sp), 바실러스속 균( Bacillus . sp), 마이크로커커스속 균( Micrococcus . sp), 프로테우스속 균( Proteus . sp) 및 살모넬라속 균( Salmonella . sp)에 대하여 우수한 항균활성을 갖는 항균 조성물에 관한 것이다. 브로모페놀계 화합물, 항균 조성물
Abstract:
PURPOSE: A method for reducing the toxicity of PCBs by reducing all chlorine atoms contained in PCBs (polychlorinated biphenyls) by using hydrogen, thereby converting the polychlorinated biphenyls into biphenyl. CONSTITUTION: The method comprises a step of mixing methanol solution saturated with sodium with a solution into which PCBs (polychlorinated biphenyls) is dissolved; a step of adding palladium-alumina catalyst to a mixed solution in which the PCBs solution is mixed with the methanol solution; and a step of applying ultrasonic waves to the mixed solution to which the palladium-alumina catalyst is added, wherein toxicity of chlorine molecules of PCBs is reduced by increasing activity of the palladium-alumina catalyst using ultrasonic waves, thereby stably conducting chemical reaction in which chlorine atoms of the PCBs are replaced with hydrogen of sodium formate.
Abstract:
PURPOSE: Provided are a biostimulating material derived from Actinomyces, an extracting method thereof and a pharmaceutical composition containing the same. The biostimulating material has toxicity to various cancer cells, so that it can be useful as an anticancer drug. CONSTITUTION: The biostimulating material derived from Actinomyces is represented by formula(1), in which R1 and R2 are the same or different, and hydrogen, methyl, ethyl, propyl or isopropyl. The method for extracting the biostimulating material derived from Actinomyces comprises the steps of: culturing Streptomyces sp. in a broth; filtering the cultured medium to isolate a mycelium; extracting the mycelium with at least one of methanol, ethanol, chloroform, acetone and dichloromethane; evaporating the crude extract solution under reduced pressure to obtain a residue; fractionating the residue according to its polarity; evaporating a polar fraction under reduced pressure to obtain a polar organic concentrate; and subjecting the polar organic concentrate to chromatography.
Abstract:
PURPOSE: Novel compounds, acalycixeniolide C, D, E and F, isolated from Acalycigorgia inermis and a producing method thereof are provided. The acalycixeniolides inhibit the growth of leukemia, and is thus used for the treatment of cancers. CONSTITUTION: The method for producing acalycixeniolide C represented by formula (1), acalycixeniolide D represented by formula (2), acalycixeniolide E represented by formula (3), and acalycixeniolide F represented by formula (4) comprises the steps of: extracting Acalycigorgia inermis with organic solvents to produce the crude extract; removing the solvent from the crude extract by heating it under reduced pressure to collect remaining substances; fractionating the remaining substances according to their polarity; removing the solvent from the fractionated polar substances by heating them under reduced pressure; and isolating and purifying the polar substances.
Abstract:
본 발명은 DNA 염기 서열을 이용한 미생물에의 표지 부착방법에 관한 것으로, 본 발명에 따른 미생물에의 표지 부착방법은, 원하는 이름표의 영문 문자열에 해당하는 DNA 염기 서열을 제작하는 단계; 제작된 문자열 염기 서열을 리게이션시켜 일련의 문자열을 만드는 단계; 문자열의 양쪽에 PCR(Polymerase Chain Reaction)용 프라이머(primer)를 부착하고 그 바깥쪽에 적당한 벡터와 리게이션할 수 있는 리스트릭션 사이트(restriction site)를 붙이는 단계; 이를 제한 효소로 처리하여 스티키 엔드(sticky end)를 만드는 단계 ; 이를 동일한 제한 효소로 처리된 벡터에 삽입하는 단계; 벡터를 원하는 미생물에 형질전환시키는 단계를 포함하여 구성되는 것을 특징으로 하여, 생물학적 오염물질의 해당 생물 폐기물에 이름표를 부착하게 하거나 개발한 기관의 영문 명칭을 표지할 수 있게 함으로써 해당 영문 명칭을 알아낼 수 있어 폐기물 등의 책임소재를 밝힐 수 있을 뿐만 아니라, 새로운 유전자를 클로닝한 플라즈마나 벡터를 개발하였을 때에도 이름표를 부착하여 그 소유권을 명시할 수 있어 미생물 이용과 관련된 분쟁의 소지를 미연에 방지할 수 있는 DNA 염기 서열을 이용한 미생물에의 표지 부착방법을 제공한다.
Abstract:
PURPOSE: Provided is a method for reducing or removing the toxicity of dioxin by converting highly toxic dioxins into non-toxic materials without using any expensive equipments, while recovering and reutilizing the used catalyst. CONSTITUTION: The method comprises the steps of: adding a formate salt and a palladium-alumina catalyst to a solution in which a dioxin is dissolved; and applying an ultrasonic wave to the mixed solution. Particularly, the dioxin is polychlorinated dibenzo-p-dioxin(PCDDs), and the formate salt is potassium formate. In the method, the chlorine atoms in PCDDs are substituted with hydrogen atom so that PCDDs are converted into dibenzo-p-dioxin.
Abstract:
The present invention provides Wondonin A of general formula (I), which is extracted from a two-sponge association of phylum Porifera (sponge) and has antiangiogenic activity, and a process for preparing the same. Wondonin A has no cytotoxicity, but has an inhibitory activity against angiogenesis which is one of the crucial mechanisms of cancer cell metastasis, thus, it can be applied not only as an anticancer drug but also as a therapeutic agent of angiogenesis-associated diseases such as cardiac ischemia, rheumatoid arthritis, and diabetes mellitus.
Abstract:
PURPOSE: A method for manufacturing phosphorylcholine having two different unsaturated fatty acids is provided to reduce the generation of by-products and to improve a low production yield by using fatty acid imidazolide or anhydride instead of fatty acid chloride. CONSTITUTION: Phosphorylcholine having two different unsaturated fatty acids represented by the formula (II) is manufactured by the following steps of: i) reacting unsaturated fatty acid of the formula (II) with N,N-carbonyldiimidazole of the formula (III), in the presence of organic solvent, to obtain fatty acid imidazolide of the formula (IV) and reacting fatty acid imidazolide of the formula (IV) with sn-glycero-3-phosphorylcholine-Cdcl2 of the formula (V), in the presence of organic base, to synthesize 1-acyl-sn-glycero-3-phosphocholine of the formula (VI); ii) reacting 1-acyl-sn-glycero-3-phosphocholine of the formula (VI) with unsaturated fatty acid of the formula (VII), in the presence of organic solvent and bases, to obtain phosphorylcholine of the formula (I) having two different unsaturated fatty acids. Equation).